We add value by understanding our sectors inside out, and release regular industry research and reports

AstraZeneca divested its Reims pharmaceutical manufacturing and distribution facility to Avara

10 Oct 2017

Results Healthcare is delighted to announce that it has advised AstraZeneca on divesting its Reims pharmaceutical packaging and distribution facility to Avara.

AZ - Avara deal photo edited

The Offering

● A state of the art pharmaceutical site based in Reims, France, with an esteemed leadership team of industry experts and an experienced workforce
● The site covers approximately 73,000 sq. metres (land area) and 23,000 sq. metres (building area) and has segregated units for each activity
● Top tier, fully compliant, commercial-scale packaging facility and distribution centre, meeting GMP & GDP quality standards under EU regulatory requirements
● Expansion opportunity in oral solid dosage manufacturing space, as well as in R&D laboratory building

Key Site Infrastructure
● Packaging unit: Covering approx. 1,900 sq. metres, packing 1.5 billion oral solid dose tablets with 7 automated packing lines including final shippers packing
● Two high speed packing lines with on line foil printing and one high speed packing line with exposure controlled primary blistering
● Year round distribution centre with a warehouse capacity of 5,900 pallets including cold chain storage, serving all AstraZeneca products in France (including direct shipment to pharmacies and
hospitals), and North West Africa (French speaking regions)
● R&D laboratories: Covering approx. 1,400 sq. metres with multiple fume hoods in place and capable of supporting a team of up to 40 scientists and support staff
● Additional R&D laboratories space: Covering approx. 1,830 sq. metres that could be modernised for current laboratory practice or office space
● Bulk tablet manufacturing space available (granulators, coating): Covering approx. 2,200 sq. metres across multiple clean rooms with some high value equipment remaining. Utilities including HVAC fully operational and production could be re-started with minimal time and cost

People and Performance
● Over 45 years of pharmaceutical manufacturing history at the facility
● Packing in excess of 1.5 billion units in over 130 SKUs
● Best in class competitive packing costs due to complete automatic packing lines
● Over 175 highly trained staff leading activities in manufacturing, distribution, quality, safety, health, environmental, technical support
and support functions.
● Operational excellence and compliance programs underpinned by lean production systems and Six-Sigma methodologies
● Attractive transitional supply agreement for qualified purchasers

For full details on the deal please see the press release here.

Results Healthcare is a leading M&A adviser focused on public and private healthcare and life science companies.

Get in Touch

Talking is a more rewarding experience than reading

If you would like to have an informal conversation about how we work, or simply to discuss the next stage of your company’s development, please contact us.

View Global Offices     SUBSCRIBE

Connect with us

Follow Results International on Twitter Follow Results International on LinkedIn Follow Results International on Facebook

Your Nearest Office